Apr 21 2015
The FDA study section reported a favorable review for the antiplatelet drug cangrelor developed by The Medicines Company, New Jersey. Read the committee report here. Cangrelor now awaits full FDA approval.
Comments (0)
Antiplatelet Therapy
No comments here.